New hope for kids with brain tumors: drug combo trial launches

NCT ID NCT06666348

First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 20 times

Summary

This study tests a new combination of two drugs (mirdametinib and vinblastine) for children and young adults with a type of slow-growing brain tumor called low-grade glioma. The goal is to find the safest dose and see how well the drugs shrink or control the tumor. About 50 participants aged 2 to 25 will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC LOW-GRADE GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Sainte-Justine

    RECRUITING

    Montreal, Quebec, H3T 1C5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Children's Hospital, London Health Sciences Centre

    RECRUITING

    London, Ontario, N6A5W9, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Childrens and Womens Health Centre of British Columbia - British Columbia Childrens Hospital

    RECRUITING

    Vancouver, British Columbia, V6H 3V4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Stollery Children's Hospital

    RECRUITING

    Edmonton, Alberta, T6G 2E1, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Hospital for Sick Children

    RECRUITING

    Toronto, Ontario, M5G 1E8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.